S&P TSX Capped Composite...

US Dollar vs CAD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

CELZ Creative Medical Technology Holdings Inc

6.20

-0.25 (-3.88%)

Last Updated: 09:06:21

Delayed by 15 minutes

Form 424B3 - Prospectus [Rule 424(b)(3)]

null

Creative Medical Technol... (NASDAQ:CELZ)
Historical Stock Chart
From Feb 2025 to Mar 2025

Click Here for more Creative Medical Technol... Charts.

Creative Medical Technol... (NASDAQ:CELZ)
Historical Stock Chart
From Mar 2024 to Mar 2025

Click Here for more Creative Medical Technol... Charts.

Creative Medical Technology Holdings Inc News

Creative Medical Technology Holdings Announces Agreements for Exercise of Warrants for $3.7 Million Gross Proceeds
Thursday 6 March 2025 (2 hours ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 20 February 2025 (2 weeks ago) • Edgar (US Regulatory)

Creative Medical Technology Holdings Applauds Presidential Initiative to Expand IVF Access, Showcasing OvaStem® Program's Success and Growth Potential
Thursday 20 February 2025 (2 weeks ago) • GlobeNewswire Inc.

Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine® Procedure using AlloStem™
Friday 14 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Creative Medical Technology Reports Positive One-Year Results for AlloStem™ Type 2 Diabetes Program
Tuesday 11 February 2025 (3 weeks ago) • GlobeNewswire Inc.

Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development
Wednesday 5 February 2025 (4 weeks ago) • GlobeNewswire Inc.

Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain
Thursday 30 January 2025 (1 month ago) • GlobeNewswire Inc.

Form 8-K - Current report
Thursday 26 December 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Wednesday 20 November 2024 (3 months ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Tuesday 19 November 2024 (3 months ago) • Edgar (US Regulatory)

Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial with Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment
Wednesday 13 November 2024 (4 months ago) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Friday 8 November 2024 (4 months ago) • Edgar (US Regulatory)

More Creative Medical Technology Holdings Inc News Articles

WisdomTree Foreign Excha...

Thomson Reuters

Xtrackers II Global Infl...

BNP Paribas Issuance

Vontobel Financial Produ...

BNP Paribas Issuance

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions